Barclays Maintains Overweight on InMode, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 91.9%

Neg 91.9% Neu 0% Pos 0%

Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $21 to $19.